Intrinsic Value of S&P & Nasdaq Contact Us

QuidelOrtho Corporation QDEL NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
1/7 Pass
SharesGrow Intrinsic Value
$0.94
-94.6%
Analyst Price Target
$30.00
+71.5%

QuidelOrtho Corporation (QDEL) — Analyst outlook / Analyst consensus target is. Based on 15 analyst ratings, the consensus is bullish — 7 Buy, 6 Hold, 2 Sell.

The consensus price target is $30.00, representing an upside of 71.5% from the current price $17.49.

Analysts estimate Earnings Per Share (EPS) of $1.81 and revenue of $2.77B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-30.16 vs est $1.81 (missed -1762.6%). 2025: actual $-16.69 vs est $2.08 (missed -902.5%). Analyst accuracy: 0%.

QDEL Stock — 12-Month Price Forecast

$30.00
▲ +71.53% Upside
Average Price Target
Based on 15 Wall Street analysts offering 12-month price targets for QuidelOrtho Corporation, the price target is $30.00.
The average price target represents a +71.53% change from the last price of $17.49.

QDEL Analyst Ratings

Buy
15
Ratings
7 Buy
6 Hold
2 Sell
Based on 15 analysts giving stock ratings to QuidelOrtho Corporation in the past 3 months
Rating breakdown
Buy
7 47%
Hold
6 40%
Sell
2 13%
47%
Buy
7 analysts
40%
Hold
6 analysts
13%
Sell
2 analysts

EPS Estimates — QDEL

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$30.16 vs Est $1.81 ▼ 106.0% off
2025 Actual –$16.69 vs Est $2.08 ▼ 112.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.

Revenue Estimates — QDEL

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $2.783B vs Est $2.774B ▲ 0.3% off
2025 Actual $2.730B vs Est $2.707B ▲ 0.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message